Jaime R Merchan Selected Research

Jaime R Merchan Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 03/2003
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 06/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018 - 05/2012
4	Hypoxia (Hypoxemia) 10/2021 - 05/2013
4	Neoplasm Metastasis (Metastasis) 01/2015 - 11/2005
3	Adenocarcinoma 02/2018 - 05/2012
3	Breast Neoplasms (Breast Cancer) 01/2015 - 06/2006
2	Carcinoma (Carcinomatosis) 01/2022 - 10/2012
2	Carcinogenesis 01/2021 - 03/2013
2	Diarrhea 01/2021 - 05/2012
2	Measles 10/2017 - 01/2015
2	Thrombocytopenia (Thrombopenia) 08/2013 - 05/2012
2	Fatigue 08/2013 - 05/2012
2	Neutropenia 05/2012 - 06/2006
1	Hypertension (High Blood Pressure) 01/2021
1	Disease Progression 01/2021
1	Alveolar Soft Part Sarcoma 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hypersensitivity (Allergy) 02/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Vesicular Stomatitis 11/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Clear-cell metastatic renal cell carcinoma 08/2013
1	Hand-Foot Syndrome 08/2013
1	Starvation 05/2013
1	Lung Neoplasms (Lung Cancer) 03/2013
1	Fever (Fevers) 05/2012
1	Retinoblastoma (Glioblastoma, Retinal) 10/2010
1	Anemia 06/2006
1	Necrosis 11/2005
1	Thrombosis (Thrombus) 11/2005

Drug/Important Bio-Agent (IBA)

5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2017 - 06/2006
4	Sunitinib (Sutent)FDA Link 01/2021 - 06/2006
4	Gemcitabine FDA Link 02/2018 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	belzutifanIBA 10/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2019
2	Lipase (Acid Lipase)FDA Link 01/2021 - 06/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2012
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 03/2015
2	130-nm albumin-bound paclitaxelIBA 02/2018 - 04/2013
2	Deoxyglucose (2 Deoxy D glucose)IBA 02/2016 - 05/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 05/2013
2	folfirinoxIBA 11/2015 - 05/2012
2	Biological ProductsIBA 01/2015 - 01/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2015 - 02/2009
2	InterferonsIBA 11/2014 - 08/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2012 - 05/2012
2	Peptide Hydrolases (Proteases)FDA Link 10/2012 - 06/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2012 - 06/2006
1	PlatinumIBA 01/2022
1	enfortumab vedotinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Everolimus FDA Link 01/2021
1	Therapeutic UsesIBA 12/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Axitinib (AG 013736)IBA 01/2019
1	Albumin-Bound Paclitaxel FDA Link 02/2018
1	Pharmaceutical PreparationsIBA 02/2016
1	ixabepilone (BMS 247550)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 03/2015
1	temsirolimus FDA Link 03/2015
1	LuciferasesIBA 01/2015
1	AnthracyclinesIBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Trastuzumab (Herceptin)FDA Link 01/2014
1	Alanine Transaminase (SGPT)IBA 08/2013
1	pazopanib FDA Link 08/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Cysteine (L-Cysteine)FDA Link 04/2013
1	AcidsIBA 04/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2013
1	Dinoprostone (PGE2)FDA Link 03/2013
1	CytokinesIBA 03/2013
1	EnzymesIBA 03/2013
1	15-hydroxyprostaglandin dehydrogenaseIBA 03/2013
1	Metalloproteases (Metalloproteinases)IBA 10/2012
1	Plasminogen Activator Inhibitor 1IBA 10/2012
1	IntegrinsIBA 10/2012
1	Cetuximab (Erbitux)FDA Link 10/2012
1	Leucovorin (Folinic Acid)FDA Link 05/2012
1	Fluorouracil (Carac)FDA LinkGeneric 05/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2012
1	beta Subunit Luteinizing HormoneIBA 10/2010
1	matrigelIBA 10/2010
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2006
1	cyclo(Arg-Pro) (CI 4)IBA 06/2006
1	AntibodiesIBA 06/2006
1	Antineoplastic Agents (Antineoplastics)IBA 06/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2006

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2014 - 05/2012
1	Oncolytic Virotherapy 01/2015
1	Intravenous Administration 01/2015
1	Stents 05/2012
1	Neoadjuvant Therapy 05/2012
1	Nephrectomy 11/2005